From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

Susan Winckler, chief executive of the Reagan-Udall Foundation for the FDA, reframed the problem: harmonizing what sponsors prepare for review matters as much as harmonizing the review structures.
The agency sent a letter to formula makers on July 13 urging vigilance in choosing ingredients, has asked international expert bodies to assess spore-forming pathogens in infant formula, and is reviewing a September report from a Reagan-Udall Foundation roundtable on formula safety.
To address those gaps, we have started engagement with the botanical community by holding a roundtable with the Reagan-Udall Foundation for the FDA to start the dialogue with key stakeholders to better understand the barriers they see.
The meeting on October 28 runs from 1:00 to 5:00 p.m. ET, in person at White Oak, or online, with registration through the Reagan-Udall Foundation.
Sutter noted that repurposing has become an administration priority, citing recent work on a Leucovorin labeling change and a Reagan-Udall Foundation meeting on repurposing.
To solicit feedback on the Rare Disease Framework Initiative from patients and disease advocates, industry, and others, the FDA will host a meeting at the FDA’s White Oak campus. The meeting will be facilitated by the Reagan-Udall Foundation for the FDA.
The agency further announced a “Fit-for-Purpose Rare Disease Framework Initiative” public meeting being convened in collaboration with the Reagan-Udall Foundation on October 28, 2026.
FDA holds a public meeting at White Oak on 28 October, facilitated by the Reagan-Udall Foundation, and Medical Daily reports comments are open through 11 December. FDA says only about 5% of rare conditions have an approved treatment.
The 2024 Reagan-Udall Foundation roundtables found low awareness of the rule among small and foreign suppliers and nonchain restaurants, and distributors have real problems with mixed-lot pallets and pick slots.